OM - Outset Medical, Inc.

Equibles Rating blended score · not investment advice

Overall

Neutral

Technical · trend & momentum Neutral

◦ 50 / 200-day cross no cross

− Price vs 200-day avg −24% below

+ Price vs 50-day avg +7% above

◦ RSI (14) 53 · neutral

+ MACD trend positive

− 52-week position 9% · near low

Sentiment · smart money Bullish

◦ Trend (MA cross) 50d $4 › 200d $6 — 200d above 50d

◦ Institutional flow 1 of 97 funds reported for Jun 30 · net 0 sh shares

− Insider flow Net -$115.7K over 90 days · 100% sells

+ Short interest 10.63% of float · ▼ -11.4% MoM · 10.6 days cover

◦ Volume signal Volume near normal

+ Institution breadth 97 holders — near 1-yr high, broad support

Fundamentals Fair

◦ Revenue growth +5% Y/Y

+ Gross margin 39%, expanding

+ EPS growth +85% Y/Y

− Free cash flow $-47.1M

− Balance sheet net debt $66.0M

Blended from price, positioning & fundamentals · daily-close · not investment advice.

Up next

Next earnings call

Aug 9, 2026 Est · unconfirmed · in 5 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 7, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Guidance & track record what management promised — and delivered

Latest guidance · from the 8-K filed May 7, 2026

Revenue · 2026 Initiated $125M – $130M

prior FY $119.48M midpoint +6.7% Y/Y

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral

2 · 2 · 2

50 / 200-day cross

no cross Neutral

Price vs 200-day avg

−24% below Bearish

Price vs 50-day avg

+7% above Bullish

RSI (14)

53 · neutral Neutral

MACD trend

positive Bullish

52-week position

9% · near low Bearish

Market signals — smart money & positioning

Bullish · 2 of 6

Trend (MA cross) No cross

50d $4 › 200d $6 — 200d above 50d

Institutional flow Flat

1 of 97 funds reported for Jun 30 · net 0 sh shares

Insider flow Distributing

Net -$115.7K over 90 days · 100% sells

Short interest Falling

10.63% of float · ▼ -11.4% MoM · 10.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

97 holders — near 1-yr high, broad support

Price context

position in its 52-week range

52-wk low $3 Now $5 · 9% 52-wk high $21

vs 200-day avg -24% vs 50-day avg +7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
Net cash used in operations	$46M	FY2025	—
Non-GAAP operating expenses non-GAAP	$25.7M	Q4 2025	—
Recurring revenue	$88.7M	FY2025	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Medical Devices — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
OM Outset Medical, Inc. this stock	$87.50M	+27.2%	+5.1%	—	10.6%
ABT Abbott Laboratories	$166.17B	-23.5%	+5.7%	26.7	1.3%
SYK Stryker Corp	$125.18B	-6.8%	+11.2%	37.8	1.6%
MDT Medtronic plc	$106.49B	-12.7%	+8.4%	22.3	1.4%
BSX Boston Scientific Corp	$67.09B	-52.7%	+5.5%	18.9	2.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders

Holders

% held: 83.2%
Reported: 1 of 97
Top holder: FMR LLC

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Falling

Shares short

2.0M

Days to cover: 10.6d
Change: -252.4K sh

View

Short Volume

Short vol %

32%

As of: Jul 2, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $290
As of: Jun 2, 2026

View

Off-Exchange

Off-exchange %

44.1%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$115.7K

Buyers / Sellers: 0 / 4

Buyers Sellers

View

Financials

Revenue (FY)

$119.5M

Net income (FY): $-81.7M
EPS diluted: $-5.37

View

Filings

SEC Filings

Latest

8-K

Filed: Jun 17, 2026
This year: 10

View

Proposed Sales

Value

$87.4K

Shares: 17.7K
Filed: Jun 3, 2026

View

Exempt Offerings

Offering

$3.9M

Filed: Jan 21, 2025

View

Earnings & Events

Earnings Calls

Last call

May 7, 2026

View

Performance

	5D	20D	120D	MTD	YTD
OM	+2.8%	+2.6%	+1.1%	+9.3%	+27.2%
SPY	+1.4%	-1.3%	+8.0%	-0.3%	+9.2%
vs SPY	+1.4%	+3.9%	-7.0%	+9.5%	+18.0%

OM

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance